Skip to content


You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

  • Ulf Petrausch1Email author,
  • Petra C Schuberth2,
  • Christian Hagedorn2,
  • Alex Soltermann3,
  • Sandra Tomaszek4,
  • Rolf Stahel2,
  • Walter Weder4 and
  • Christoph Renner1, 2
BMC Cancer201212:615

Received: 5 November 2012

Accepted: 18 December 2012

Published: 22 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
5 Nov 2012 Submitted Original manuscript
3 Dec 2012 Author responded Author comments - Ulf Petrausch
Resubmission - Version 2
3 Dec 2012 Submitted Manuscript version 2
18 Dec 2012 Editorially accepted
22 Dec 2012 Article published 10.1186/1471-2407-12-615

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Department of Immunology, University Hospital Zurich
Department of Oncology, University Hospital Zurich
Institute of Surgical Pathology, University Hospital Zurich
Division of Thoracic Surgery, University Hospital Zurich